The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Evolution of Drug Resistance in Mycobacterium tuberculosis : Clinical and Molecular Perspective
Open accessAbstract
The story of antituberculosis chemotherapy is a miniature of the history of anti-infective chemotherapy. In the first half of the 20th century the problem of tuberculosis appeared insoluble: the lipid-rich cell wall was believed to make chemotherapy impossible ([21][1]). This gloomy view seemed to
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of bacteria from virus sensitivity to virus resistance
Luria, S. E., & Delbrück, M. (1943) · Genetics · doi:10.1093/genetics/28.6.491 · Cited by 3,894
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
McKinney, J. D., zu Bentrup, K. H., Muñoz-Elías, E. J., Miczak, A., Chen, B., Chan, W.-T., Swenson, D., Sacchettini, J. C., Jacobs, W. R., & Russell, D. G. (2000) · Nature · doi:10.1038/35021074 · Cited by 1,360
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Ramaswamy, S., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,089
Edlin, B. R., Tokars, J. I., Grieco, M. H., Crawford, J. T., Williams, J., Sordillo, E. M., Ong, K. R., Kilburn, J. O., Dooley, S. W., Castro, K. G., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206043262302 · Cited by 861
Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997
Pablos-Méndez, A., Raviglione, M. C., Laszlo, A., Binkin, N., Rieder, H. L., Bustreo, F., Cohn, D. L., Lambregts-van Weezenbeek, C. S. B., Kim, S. J., Chaulet, P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382301 · Cited by 815
Alland, D., Kalkut, G. E., Moss, A. R., McAdam, R. A., Hahn, J. A., Bosworth, W., Drucker, E., & Bloom, B. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406163302403 · Cited by 799
Fox, W., Ellard, G. A., & Mitchison, D. A. (1999) · PubMed · Cited by 797
The action of antituberculosis drugs in short-course chemotherapy
Mitchison, D. A. (1985) · Tubercle · doi:10.1016/0041-3879(85)90040-6 · Cited by 518
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Jindani, A., Aber, V. R., Edwards, E. A., & Mitchison, D. A. (1980) · PubMed · doi:10.1164/arrd.1980.121.6.939 · Cited by 487
Effects of Environment on Compensatory Mutations to Ameliorate Costs of Antibiotic Resistance
Björkman, J., Nagaev, I., Berg, O. G., Hughes, D., & Andersson, D. I. (2000) · Science · doi:10.1126/science.287.5457.1479 · Cited by 452
Adaptation to the fitness costs of antibiotic resistance in Escherichia coli
Schrag, S. J., Perrot, V., & Levin, B. R. (1997) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1997.0178 · Cited by 396
Dormancy ofMycobacterium tuberculosis and latency of disease
Wayne, L. G. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02111491 · Cited by 387
Fischl, M. A., Uttamchandani, R. B., Daikos, G. L., Poblete, R. B., Moreno, J. N., Reyes, R. R., Boota, A. M., Thompson, L. M., Cleary, T. J., & Lai, S. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-177 · Cited by 371
Virulence of antibiotic-resistant Salmonella typhimurium
Björkman, J., Hughes, D., & Andersson, D. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3949 · Cited by 343
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations
Sreevatsan, S., Stockbauer, K. E., Pan, X., Kreiswirth, B. N., Moghazeh, S. L., Jacobs, W. R., Telenti, A., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1677 · Cited by 335
Heym, B., Alzari, P. M., Honore, N., & Cole, S. T. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02238.x · Cited by 330
David, H. L. (1970) · Applied Microbiology · doi:10.1128/aem.20.5.810-814.1970 · Cited by 317
Combs, D. L., O'Brien, R. J., & Geiter, L. J. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-397 · Cited by 315
PARA-AMINOSALICYLIC ACID IN THE TREATMENT OF TUBERCULOSIS
Lehmann, J. (1946) · The Lancet · doi:10.1016/s0140-6736(46)91185-3 · Cited by 295
Streptomycin Resistance in Pulmonary Tuberculosis
Crofton, J., & Mitchison, D. A. (1948) · BMJ · doi:10.1136/bmj.2.4588.1009 · Cited by 261
Schatz, A., & Waksman, S. A. (1944) · Experimental Biology and Medicine · doi:10.3181/00379727-57-14769 · Cited by 251
CANETTI, G. (1956) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195604000-00012 · Cited by 219
The Distribution of Rates of Spontaneous Mutation over Viruses, Prokaryotes, and Eukaryotes
DRAKE, J. W. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08870.x · Cited by 204
Zhang, Y., Garbe, T., & Young, D. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01596.x · Cited by 179
Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis
Wilson, T. M., de Lisle, G. W., & Collins, D. M. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02276.x · Cited by 166
Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis
Hirano, K., Takahashi, M., Kazumi, Y., Fukasawa, Y., & Abe, C. (1998) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(98)80004-x · Cited by 163
Heep, M., Rieger, U., Beck, D., & Lehn, N. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.1075-1077.2000 · Cited by 153
Sreevatsan, S., Pan, X., Zhang, Y., Deretic, V. P., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.600 · Cited by 152
Zhou, J., Dong, Y., Zhao, X., Lee, S., Amin, A. G., Ramaswamy, S. V., Domagala, J. M., Musser, J. M., & Drlica, K. (2000) · The Journal of Infectious Diseases · doi:10.1086/315708 · Cited by 148
Will tuberculosis become resistant to all antibiotics?
Dye, C., & Espinal, M. (2001) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2000.1328 · Cited by 148
Fitness of antibiotic-resistant microorganisms and compensatory mutations
Böttger, E. C., Springer, B., Pletschette, M., & Sander, P. (1998) · Nature Medicine · doi:10.1038/3906 · Cited by 138
Dong, Y., Zhao, X., Kreiswirth, B. N., & Drlica, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2581-2584.2000 · Cited by 128
Stewart, F. M., Gordon, D. M., & Levin, B. R. (1990) · Genetics · doi:10.1093/genetics/124.1.175 · Cited by 126
Lipsitch, M., & Br, L. (1998) · PubMed · Cited by 123
Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice
Ordway, D. J., Sonnenberg, M. G., Donahue, S. A., Belisle, J. T., & Orme, I. M. (1995) · Infection and Immunity · doi:10.1128/iai.63.2.741-743.1995 · Cited by 120
A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York.
Moss, A. R., Alland, D., Telzak, E. E., Hewlett, D., Sharp, V., Chiliade, P., LaBombardi, V. J., Kabus, D., Hanna, B. A., Palumbo, L., et al. (1997) · PubMed · Cited by 117
Luria-Delbrück fluctuation experiments: design and analysis.
Jones, M. E., Thomas, S. M., & Rogers, A. (1994) · Genetics · doi:10.1093/genetics/136.3.1209 · Cited by 107
Risk Factors for Rifampin Mono-resistant Tuberculosis
Ridzon, R., Whitney, C. G., McKenna, M. T., Taylor, J. P., Ashkar, S. H., Nitta, A. T., Harvey, S. M., Valway, S. E., Woodley, C. L., Cooksey, R. C., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9712009 · Cited by 95
The Neglected Global Tuberculosis Problem: A Report of the 1992 World Congress on Tuberculosis
Snider, D. E., & Montagne, J. R. L. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.6.1189 · Cited by 86
Pea chloroplast carnitine acetyltransferase
Masterson, C., & Wood, C. (2000) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2000.0958 · Cited by 85
Pyle, M. M. (1947) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)10603-4 · Cited by 83
Tuberculosis 2000-2010: control, but not elimination.
Dye, C. (2000) · PubMed · Cited by 70
Davies, A. P., Billington, O. J., Bannister, B. A., et al. (2000) · Journal of Infection · doi:10.1053/jinf.2000.0711 · Cited by 62
Clinical Evaluation of Isoniazid
Middlebrook, G., & DRESSLER, S. H. (1954) · American Review of Tuberculosis · doi:10.1164/art.1954.70.6.1102 · Cited by 57
The annual risk of infection with Mycobacterium tuberculosis in England and Wales since 1901.
Vynnycky, E., & Fine, P. (1997) · PubMed · Cited by 56
The molecular basis of isoniazid resistance in Mycobacterium tuberculosis
Heym, B., Saint‐Joanis, B., & Cole, S. T. (1999) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0208 · Cited by 54
Barnett, M., BUSBY, S. R., & Mitchison, D. A. (1953) · PubMed · Cited by 48
In vitro studies on isonicotinic acid hydrazide.
PANSY, F. E., Stander, H. J., & Donovick, R. (1952) · PubMed · Cited by 42
Hughes, A. L. (1993) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040064 · Cited by 31
Bacterial resistance studies with derivatives of isonicotinic acid.
Szybalski, W., & BRYSON, V. (1952) · PubMed · Cited by 25
Vennesland, K., Ebert, R. H., & Bloch, R. G. (1947) · Science · doi:10.1126/science.106.2759.476 · Cited by 23
Rinder, H., Feldmann, K., Tortoli, E., Grosset, J. H. E., Casal, M., RICHTER, E., Rifai, M., Jarlier, V., VAQUERO, M., & Rüsch-Gerdes, S. (1999) · Molecular Diagnosis · doi:10.1016/s1084-8592(99)80038-1 · Cited by 12
Cited by
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., Furin, J., Nardell, E. A., London, L., Lessem, E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30079-6 · Cited by 684
Molecular Insights into Aminoglycoside Action and Resistance
Magnet, S., & Blanchard, J. S. (2005) · Chemical Reviews · doi:10.1021/cr0301088 · Cited by 669
Metadata
- Authors
- Gillespie, S. H.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2002-02
- Volume
- 46
- Issue
- 2
- Pages
- 267-274
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2143607548
- Cited by
- 412
- References
- 54
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.